Status:
RECRUITING
MR-BIO: a Study to Evaluate Changes in MR Imaging and Biological Parameters
Lead Sponsor:
University of Manchester
Collaborating Sponsors:
The Christie NHS Foundation Trust
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The MR BIO study aims to understand the changes in the tumour and normal tissues during a course of radiotherapy. This is accomplished by studying the MR images taken during each treatment session on ...
Eligibility Criteria
Inclusion
- Be willing and able to provide written consent. Over 18 years of age. Undergo and satisfy MRI Safety Screening Patient volunteers must be under the care of a clinical oncologist at The Christie NHS Foundation Trust and be planned to receive radiotherapy to the target site to be imaged.
- Patient volunteers must be able to give blood and/or urine sample as required through the treatment period.
- Non-patient (healthy) volunteers must have no known or suspected significant medical condition.
Exclusion
- The following apply to both patients and healthy volunteers:
- Any conditions that would be a contra-indication to MRI including:
- Failure to satisfy MRI Safety Screening Form
- Implanted pacemakers and/or pacing wires
- Cochlear implants
- Programmable hydrocephalus shunts
- Ferromagnetic implants
- Unable to tolerate MR scans
- Known HIV or active HepB or C
- Pregnancy Healthy volunteers must not be a member of the study team.
Key Trial Info
Start Date :
October 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04903236
Start Date
October 20 2020
End Date
December 31 2025
Last Update
January 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Christie NHS Foundation Trust
Manchester, United Kingdom, M20 4BX